[Application of nanoparticles in CRISPR/Cas9-based gene therapy]

Area of Science:

• Biotechnology
• Nanomedicine
• Gene Therapy

Background:

• CRISPR/Cas9 is a revolutionary gene-editing tool with significant therapeutic potential.
• Efficient and safe delivery of CRISPR/Cas9 components remains a critical challenge for clinical translation.
• Nanoparticles offer tunable properties for enhanced drug delivery and therapeutic applications.

Purpose of the Study:

• To review the characteristics of various nanoparticles for gene therapy applications.
• To discuss the application of nanoparticles in delivering CRISPR/Cas9 gene editing systems.
• To evaluate the challenges and safety considerations of nanoparticle-mediated CRISPR/Cas9 delivery.

Main Methods:

• Literature review of nanoparticle types (lipid-based, polymer, gold, biofilm).
• Analysis of CRISPR/Cas9 delivery strategies using different nanoparticle formulations.
• Discussion of current challenges and safety aspects in nanoparticle-based gene therapy.

Main Results:

• Nanoparticles exhibit favorable biocompatibility, safety, and designability for gene delivery.
• Diverse nanoparticle platforms show potential for delivering CRISPR/Cas9 components effectively.
• Key challenges include optimizing delivery efficiency, off-target effects, and immunogenicity.

Conclusions:

• Nanoparticle-mediated delivery holds significant promise for advancing CRISPR/Cas9 gene therapy.
• Further research is needed to address safety and efficacy challenges for clinical implementation.
• Nanotechnology offers innovative solutions for precise and targeted gene editing therapies.